A phase 1b clinical trial of dacetuzumab in combination with rituximab and gemcitabine: Multiple responses observed in patients with relapsed diffuse large B-cell lymphoma Meeting Abstract
| Authors: | Forero-Torres, A.; Bartlett, N. L.; Nasta, S. D.; Northfelt, D.; Beaven, A.; Myint, H.; Whiting, N. C.; Drachman, J. G.; Moskowitz, C. H. |
| Abstract Title: | A phase 1b clinical trial of dacetuzumab in combination with rituximab and gemcitabine: Multiple responses observed in patients with relapsed diffuse large B-cell lymphoma |
| Meeting Title: | 51st Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 114 |
| Issue: | 22 |
| Meeting Dates: | 2009 Dec 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2009-11-20 |
| Start Page: | 243 |
| End Page: | 244 |
| Language: | English |
| ACCESSION: | WOS:000272725800587 |
| PROVIDER: | wos |
| PUBMED: | 22276299 |
| DOI: | 10.1182/blood.V114.22.586.586 |
| Notes: | Meeting Abstract: 586 -- Source: Wos |
